VIMOVO
AstraZeneca UK Limited
Application Filed: 2009-02-13
Trademark Application Details
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77670350 |
| Registration Number | 3941225 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Wm. Charles Saunders |
| Attorney Docket Number | Z20466/US/3 |
| Law Office Assigned | L70 |
| Employee Name | DE JONGE, KATHLEEN RUS |
Timeline
| 2009-02-13 | Application Filed |
| 2009-06-09 | Published for Opposition |
| 2010-08-06 | Date of First Use |
| 2011-04-05 | Trademark Registered |
| 2017-03-14 | Location: TMEG LAW OFFICE 107 |
| 2017-03-14 | Status: Live/Registered |
| 2019-02-11 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  AstraZeneca UK Limited |
| Address | 15 Stanhope Gate London GB W1Y6LN |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| TR0010 | The wording "VIMOVO" has no meaning in a foreign language. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2009-02-18 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2009-02-18 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2009-05-05 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2009-05-05 | 4 CNSA P: |
| ASSIGNED TO LIE | 2009-05-05 | 5 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2009-05-05 | 6 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2009-05-20 | 7 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2009-06-09 | 8 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2009-09-01 | 9 NOAM O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2010-03-01 | 10 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2010-03-30 | 11 AITU A:Allowance for Publication |
| EXTENSION 1 FILED | 2010-03-01 | 12 EXT1 S: |
| EXTENSION 1 GRANTED | 2010-03-30 | 13 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2010-03-31 | 14 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2010-08-05 | 15 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2010-08-05 | 16 EXT2 S: |
| EXTENSION 2 GRANTED | 2010-08-10 | 17 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2010-08-11 | 18 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2011-02-24 | 19 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2011-02-24 | 20 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2011-03-01 | 21 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2011-03-02 | 22 CNPR P: |
| LAW OFFICE REGISTRATION REVIEW COMPLETED | 2011-03-02 | 23 REGV O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2011-03-03 | 24 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2011-04-05 | 25 R.PR A:Allowance for Publication |
| TEAS SECTION 8 & 15 RECEIVED | 2017-01-11 | 26 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2017-03-14 | 27 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2017-03-14 | 28 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2017-03-14 | 29 NA85 E:E-Mail |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-02-08 | 30 TCCA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2020-04-05 | 31 REM2 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2021-01-13 | 32 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2021-04-24 | 33 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2021-04-24 | 34 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2021-04-24 | 35 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2021-04-24 | 36 NA89 E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-07-22 | 37 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-07-22 | 38 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-07-22 | 39 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2021-07-22 | 40 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-07-22 | 41 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-07-22 | 42 CHAN I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 VIMOVO 77726998 3914867 Dead/Cancelled |
AstraZeneca UK Limited 2009-05-01 |
 VIMOVO 77670350 3941225 Live/Registered |
AstraZeneca UK Limited 2009-02-13 |
 VIMOVO 77475260 not registered Dead/Abandoned |
AstraZeneca UK Limited 2008-05-15 |
 VIMOVO 75809739 2629729 Dead/Cancelled |
Zeneca Limited 1999-09-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 